title: Quantification of Epstein-Barr viral load and determination of a cut-off value to predict the risk of post-transplant lymphoproliferative disease in a renal transplant cohort.
abstract: Post-transplant lymphoproliferative disorder (PTLD) is a life-threatening Epstein-Barr virus (EBV)-driven B-cell malignancy occurring in 1 to 3% of renal transplant patients. Recently, EBV DNA quantification has become a useful tool for identifying patients at risk of developing PTLD. However, studies on EBV load differ in design, methodology and type of patients.
authors.forename: Otávio C G
authors.initials: OC
authors.lastname: Baiocchi
authors.forename: Gisele W B
authors.initials: GW
authors.lastname: Colleoni
authors.forename: Otávia L
authors.initials: OL
authors.lastname: Caballero
authors.forename: André L
authors.initials: AL
authors.lastname: Vettore
authors.forename: Ana Lucia S S
authors.initials: AL
authors.lastname: Andrade
authors.forename: José O M
authors.initials: JO
authors.lastname: Pestana
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D020031:Epstein-Barr Virus Infections / Q000097:blood*; D005260:Female; D004854:Herpesvirus 4, Human; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000821:virology*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D019562:Viral Load